Vendor review
Guangzhou Aoyu reviews
Guangzhou Aoyu reviews from 18 independent lab tests (Tirzepatide, Retatrutide and Tesamorelin): grade A, purity and fill accuracy. Is Guangzhou Aoyu legit? See what its vials showed.
What the lab tests show
18 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | Retatrutide | 10 mg | Fail | View | |
| Sep 24, 2026 | Retatrutide | 99.8 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Aug 3, 2026 | Tesamorelin | 98.2 % | 8.66 mg of 10 mg (-13 %) | Pass | View |
| Jul 22, 2026 | Retatrutide | 99.9 % | 21 mg of 20 mg (5 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.7 % | 60.8 mg of 60 mg (1 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.8 % | 10 mg of 10 mg (0 %) | Pass | View |
| Jun 16, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Jun 16, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jun 15, 2026 | Tirzepatide | 99.9 % | 27.4 mg of 30 mg (-9 %) | Pass | View |
| Jun 15, 2026 | Retatrutide | 99.9 % | 26.1 mg of 20 mg (31 %) | Pass | View |
| Jun 8, 2026 | MOTS-c | 10 mg | Fail | View | |
| Jun 6, 2026 | Tirzepatide | 60 mg | Fail | View | |
| Jun 4, 2026 | Tirzepatide | 20 mg | Fail | View | |
| May 27, 2026 | Tesamorelin | 10 mg | Fail | View | |
| May 20, 2026 | MOTS-c | 98.8 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| May 19, 2026 | Retatrutide | 99.9 % | 8.76 mg of 10 mg (-12 %) | Pass | View |
| May 6, 2026 | Tirzepatide | 99.9 % | 26.8 mg of 30 mg (-11 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
What Guangzhou Aoyu sells
No current listings on record.
About Guangzhou Aoyu
Finnrick has tested 18 samples from Guangzhou Aoyu across 4 products.